CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 145 enrolled
Drug / intervention
PEIT +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00397540
NCT00397540N/ACompleted
CompareCT.gov

Prospective Cohort Study of the Effect of Serum HBV DNA Level on Intrahepatic Recurrence in Locally Treatable, HBV-related HCC Patients

Seoul National University Hospital·interventional·Posted Nov 9, 2006·Updated Mar 18, 2019

In Brief

A clinical study evaluating PEIT and RFTA for Carcinoma, Hepatocellular and Chronic Hepatitis B. Completed, enrolled 145 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effect of serum hepatitis B virus (HBV) DNA level on intrahepatic recurrence in locally treatable hepatocellular carcinomas (HCCs) related with HBV.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarcinoma, Hepatocellular, Chronic Hepatitis B
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 9, 2006
Enrollment StartOct 1, 2004
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 19.6 years ago

Interventions

PEITprocedure

Percutaneous Ethanol Injection Therapy

RFTAprocedure

Radiofrequency Thermal Ablation